Hartford Financial Management’s Citius Pharmaceuticals CTXR Stock Holding History

Hartford Financial Management’s Portfolio CTXR Stock Details CTXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-20	Closed	-$1K	–	412
2018 Q1	$1K	Hold	20	–	–	﹤0.01%	330
2017 Q4	$1K	Buy	+20	New	+$2K	﹤0.01%	330

Other funds holding CTXR

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Hartford Financial Management's CTXR Position: Q2 2018 in Review

Hartford Financial Management sold out of Citius Pharmaceuticals (CTXR) in Q2 2018, closing a stake of 20 shares — an estimated $1K sold.

Hartford Financial Management first reported a position in CTXR in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q1 2018. 7 funds tracked by Wall St. Rank hold CTXR as of Q2 2018.

Hartford Financial Management reported no remaining Citius Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Hartford Financial Management sold 20 Citius Pharmaceuticals shares in Q2 2018, an estimated $1K.
Hartford Financial Management first reported a position in Citius Pharmaceuticals in Q4 2017 and held it in 2 quarters.
Hartford Financial Management's Citius Pharmaceuticals position peaked at $1K in Q1 2018.
7 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2018.

Based on Hartford Financial Management's 13F filing for Q2 2018, filed 10 Aug 2018.